Literature DB >> 32615559

Often Overlooked and Ignored, but Do Not Underestimate Its Relevance: ADHD in Addiction - Addiction in ADHD.

Arnt F A Schellekens1,2, Wim van den Brink3, Falk Kiefer4,5, Anneke E Goudriaan6,7.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32615559      PMCID： PMC7949230          DOI： 10.1159/000509267

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN： 1022-6877            Impact factor:   3.015


× No keyword cloud information.
  37 in total

1.  Temporal association between childhood psychopathology and substance use disorders: findings from a sample of adults with opioid or alcohol dependency.

Authors:  Amy L Hahesy; Timothy E Wilens; Joseph Biederman; Stephanie L Van Patten; Thomas Spencer
Journal:  Psychiatry Res       Date:  2002-04-15       Impact factor: 3.222

Review 2.  The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review.

Authors:  Erik G Willcutt
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

3.  Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.

Authors:  Frances R Levin; John J Mariani; Sheila Specker; Marc Mooney; Amy Mahony; Daniel J Brooks; David Babb; Yun Bai; Lynn E Eberly; Edward V Nunes; John Grabowski
Journal:  JAMA Psychiatry       Date:  2015-06       Impact factor: 21.596

4.  Genetic influences on ADHD symptom dimensions: Examination of a priori candidates, gene-based tests, genome-wide variation, and SNP heritability.

Authors:  L Cinnamon Bidwell; Joshua C Gray; Jessica Weafer; Abraham A Palmer; Harriet de Wit; James MacKillop
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-06       Impact factor: 3.568

5.  Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.

Authors:  Annabeth P Groenman; Jaap Oosterlaan; Nanda Rommelse; Barbara Franke; Herbert Roeyers; Robert D Oades; Joseph A Sergeant; Jan K Buitelaar; Stephen V Faraone
Journal:  Addiction       Date:  2013-04-22       Impact factor: 6.526

6.  Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.

Authors:  Timothy E Wilens; Joel Adamson; Michael C Monuteaux; Stephen V Faraone; Mary Schillinger; Diana Westerberg; Joseph Biederman
Journal:  Arch Pediatr Adolesc Med       Date:  2008-10

Review 7.  Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.

Authors:  Stephen V Faraone; Timothy E Wilens
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

8.  Prediction of drop-out and outcome in integrated cognitive behavioral therapy for ADHD and SUD: Results from a randomized clinical trial.

Authors:  Katelijne van Emmerik-van Oortmerssen; Matthijs Blankers; Ellen Vedel; Floor Kramer; Anna E Goudriaan; Wim van den Brink; Robert A Schoevers
Journal:  Addict Behav       Date:  2019-12-03       Impact factor: 3.913

9.  A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.

Authors:  Stephen V Faraone; Joseph Biederman; Timothy E Wilens; Joel Adamson
Journal:  Psychol Med       Date:  2007-03-12       Impact factor: 7.723

10.  Disruption of Reward Processing in Addiction : An Image-Based Meta-analysis of Functional Magnetic Resonance Imaging Studies.

Authors:  Maartje Luijten; Arnt F Schellekens; Simone Kühn; Marise W J Machielse; Guillaume Sescousse
Journal:  JAMA Psychiatry       Date:  2017-04-01       Impact factor: 21.596
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.